臨床試驗受試者招募原則之修正建議

近來新型冠狀病毒疫苗試驗在國內招募受試者時，有人認為政府或社會名人，不可鼓勵民眾參加試驗，因為會違反「臨床試驗受試者招募原則」。本文即分析此爭議及人體研究倫理審查委員會在審查招募廣告時遇到的相關疑義。我們發現對於招募原則的規範對象，以及參加研究意向的登記平台，存在一些誤解。因此，審查招募廣告的主管機關及人體研究倫理審查委員會應了解到，招募廣告是憲法所保障的言論自由範疇，在審查時要避免給予過度的限制。另外，為了釐清現行規範的疑義，並減少未來的誤解，本文也對「臨床試驗受試者招募原則」提出修正建議。

關鍵字

臨床試驗招募廣告；臨床試驗；人體研究倫理審查委員會；受試者招募平台

並列摘要

Recently there has been a controversy surrounding the Covid-19 vaccine trials recruitment in Taiwan. Some argue that the government and celebrities should not promote trial recruitment because it is against the regulation for recruiting study subjects for drug clinical trials. The authors analyze this controversy and the related issues presented to the Institutional Review Board (IRB) when reviewing recruitment advertisement. We found that the scope of recruitment regulation and the practice of recruitment through research subject pools may have been misinterpreted. Furthermore, reviewers of drug administration and IRB should be mindful that recruitment advertisement is protected by the freedom of speech, and should avoid placing unnecessary restrictions on it. To clarify the ambiguity in recruitment regulation and to circumvent similar conflicts that may arise, we propose to amend the current recruitment regulation.

並列關鍵字

clinical trial advertising materials ； clinical trial ； institutional review board ； research subject pool

參考文獻

黃怡璇、葉美妤、蔣詩偉等：數位乳房攝影系統之物理測試建議書。台灣醫學 2018;22:311-23。 doi: 10.6320/FJM.201805_22(3).0010

林妤穎、蔡惠予、吳宇恩等：數位乳房斷層層析攝影劑量之全國性評估。台灣醫學2018; 23:298-309。 doi: 10.6320/FJM.201905_23(3).0002

Samei E, Badano A, Chakraborty D, et al. Assessment of display performance for medical imaging systems: executive summary of AAPM TG18 report. Med Phys 2005;32:1205-25. doi: 10.1118/1.1861159

Heggie JCP, Barnes P, Cartwright L, et al. Position paper: recommendations for a digital mammography quality assurance program V4.0. Australas Phys Eng Sci Med 2017;40:491-543. doi: 10.1007/s13246-017-0583-x

Dance DR, Young KC, van Engen RE. Estimation of mean glandular dose for breast tomosynthesis: factors for use with the UK, European and IAEA breast dosimetry protocols. Phys Med Biol 2011;56:453-71. doi: 10.1088/0031-9155/56/2/011

主題瀏覽